FASEB J. Uncover Your Biological Pathway
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TOMATIS, L.
Right arrow Articles by HUFF, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TOMATIS, L.
Right arrow Articles by HUFF, J.
(The FASEB Journal. 2001;15:195-203.)
© 2001 FASEB

Alleged ‘misconceptions’ distort perceptions of environmental cancer risks

LORENZO TOMATIS1, RONALD L. MELNICK, JOSEPH HASEMAN, J. CARL BARRETT2 and JAMES HUFF3

National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA

3Correspondence: National Institute of Environmental Health Sciences, 111 Alexander Dr., Research Triangle Park, NC 27709, USA. E-mail: huff1{at}niehs.nih.gov


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
THE HERP INDEX: IS...
THE VALUE OF ANIMAL...
HEALTH RISKS FROM NATURAL...
ALLEGED MISCONCEPTIONS: HAVE THE...
DISCUSSION
CONCLUSION
REFERENCES
 
In a series of papers, Ames and colleagues allege that the scientific and public health communities have perpetuated a series of ‘misconceptions’ that resulted in inaccurate identification of chemicals that pose potential human cancer risks, and misguided cancer prevention strategies and regulatory policies. They conclude that exposures to industrial and synthetic chemicals represent negligible cancer risks and that animal studies have little or no scientific value for assessing human risks. Their conclusions are based on flawed and untested assumptions. For instance, they claim that synthetic residues on food can be ignored because 99.99% of pesticides humans eat are natural, chemicals in plants are pesticides, and their potential to cause cancer equals that of synthetic pesticides. Similarly, Ames does not offer any convincing scientific evidence to justify discrediting bioassays for identifying human carcinogens. Ironically, their arguments center on a ranking procedure that relies on the same experimental data and extrapolation methods they criticize as being unreliable for evaluating cancer risks. We address their inconsistencies and flaws, and present scientific facts and our perspectives surrounding Ames’ nine alleged misconceptions. Our conclusions agree with the International Agency for Research on Cancer, the National Toxicology Program, and other respected scientific organizations: in the absence of human data, animal studies are the most definitive for assessing human cancer risks. Animal data should not be ignored, and precautions should be taken to lessen human exposures. Dismissing animal carcinogenicity findings would lead to human cancer cases as the only means of demonstrating carcinogenicity of environmental agents. This is unacceptable public health policy.—Tomatis, L., Melnick, R. L., Haseman, J., Barrett, J. C., Huff, J. Alleged ‘misconceptions’ distort perceptions of environmental cancer risks.


Key Words: environmental carcinogens • assessment of risks • cancer prevention • carcinogenesis bioassay


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
THE HERP INDEX: IS...
THE VALUE OF ANIMAL...
HEALTH RISKS FROM NATURAL...
ALLEGED MISCONCEPTIONS: HAVE THE...
DISCUSSION
CONCLUSION
REFERENCES
 
CANCER IS THE second leading cause of death in the United States; more than 1 million new cancer cases (2 million if skin tumors are included) are diagnosed, with 600,000 cancer deaths each year (1 , 2) . Even though much is known about certain causes of cancer (e.g., occupational exposures, tobacco smoking, and treatment with cancer chemotherapeutic agents), the etiologies of most cancers remain unknown (3 , 4) . Other widely accepted factors influencing cancer causation include exposures to occupational, industrial, and environmental agents (which include synthetic and natural chemicals), genetic risks, health status, age, diet, and lifestyle. Several investigators (3 , 5 6 7) have concluded that a considerable proportion of cancers are preventable.

Implementation of effective prevention plans (e.g., avoiding hazardous occupational exposures, reducing tobacco smoking, reducing exposures to sunlight) could go far to ease this societal cancer burden (8 9 10) . Likewise, reducing or eliminating exposures to cancer-causing agents could have a substantial effect on reducing cancer incidence, morbidity, and mortality (11) . A better understanding of mechanisms of carcinogenesis and of differences in susceptibility can strengthen the scientific basis for risk reduction with lowered exposures, especially for sensitive subpopulations. However, a complete knowledge of the mechanisms contributing to these diseases is not required to recognize the need to eliminate or reduce exposures to known cancer-causing substances.

Whereas exposure to tobacco smoke, the most widespread cause of human cancer, is decreasing in males (at least in certain industrialized countries), exposure to other environmental carcinogens is increasing (11) , and contamination of air, soil, and water is reaching levels of serious concern (12) . Unfortunately, cancer prevention initiatives, despite being the most relevant approach to reduce cancer incidence, are not considered high priorities in many health research programs (9 , 13) .

After the considerable effort devoted to cancer research and prevention, cancer incidences and mortality from certain cancers fortunately appear to be decreasing (14) . For all sites combined, cancer incidence rates decreased on average 0.7% per year during the years 1990–1995, and cancer deaths rates for all sites combined decreased on average 0.5% per year during the same period, after significantly increasing 0.4% per year during 1973–1990. This historic first time shift in cancer incidence and mortality is most welcome, but steady increases in certain cancer rates at several specific sites continue to be an important public health concern.

In 1976, Ames and colleagues stressed that "we are living in a sea of chemicals that have not been tested for mutagenicity and carcinogenicity" and that "thousands of chemicals to which humans have been exposed have been introduced into the environment without adequate toxicological testing" (15) . They were most concerned with the "halogenated and industrial chemicals to which humans have unwittingly been exposed" (16) and that "a steep increase in human cancer may be the outcome if too many of the thousands of new chemicals to which humans have been exposed turn out to be powerful mutagens and carcinogens" (17) . In 1987, Ames and colleagues concluded that in addition to epidemiological findings, "animal bioassays and in vitro studies are also providing clues as to which carcinogens and mutagens might be contributing to human cancer" (18) .

More recently, however, Ames and colleagues have adopted and advocated the view that exposure to industrial and synthetic chemicals represents little carcinogenic risk to humans (19 , 20) . This perspective has led to their claim of nine ‘misconceptions’ relating to environmental pollution, health risks from pesticide residues, methods of identifying chemical carcinogens, and cancer prevention strategies. In this commentary, we examine several underlying assumptions in three critical issues that form the primary basis of these alleged misconceptions: the HERP (Human Exposure/Rodent Potency) index, the value of animal cancer data, and health risks from natural chemicals vs. synthetic chemicals. This is followed by a summation of the facts surrounding each of the nine alleged misconceptions, together with our perspective on each.


   THE HERP INDEX: IS THIS A VALID PROCEDURE FOR COMPARING CANCER RISKS?
TOP
ABSTRACT
INTRODUCTION
THE HERP INDEX: IS...
THE VALUE OF ANIMAL...
HEALTH RISKS FROM NATURAL...
ALLEGED MISCONCEPTIONS: HAVE THE...
DISCUSSION
CONCLUSION
REFERENCES
 
The formulation of the nine alleged misconceptions relies heavily on procedures used to rank possible carcinogenic hazards to exposed humans. Ames and colleagues devised a ranking scheme in which human exposures are given as percentages of carcinogenic potency in rodents to produce a HERP index. The carcinogenic potency is drawn from the Carcinogenesis Potency Database (CPDB) that they developed and maintained (21 22 23) .

Although the authors caution that "it would be a mistake to use our HERP index as a direct estimate of human hazard" (18) , they nevertheless use it as a "reasonable strategy" to compare and rank possible carcinogenic hazards to humans (24) . Using this approach, agents with higher values are considered more dangerous from a public health point of view than are agents with lower values, and equivalent HERP indexes imply equivalent carcinogenic risks to humans. For example, Ames states that "Water from the most polluted well [in Silicon Valley]... has a HERP value orders of magnitude less than for the carcinogens in an equal amount of soda, beer, or wine" or in "the average peanut butter sandwich" (19) . They further conclude that the carcinogenic potential of the reference dose of TCDD (6 fg per kilogram per day) is "equivalent to the alcohol in ingesting one beer every 345 years" (25) . Such frivolous comparisons have led Ames to conclude that "pollution is pretty much irrelevant to cancer" (26) . We disagree with this assertion and the methods used to draw these conclusions.

In the absence of adequate human data, a method that combines cancer potency based on animal carcinogenesis data with information on the prevalence and levels of human exposures in an attempt to estimate cancer risk could be quite useful. Further, in the absence of contrary mechanistic information, it is reasonable to assume a linear dose-response relationship. Indeed, this is what the Environmental Protection Agency (EPA) does in estimating environmental cancer risks. The difference between Ames’ HERP index and EPA’s risk assessment is that EPA takes a more rigorous approach in assessing human exposure and in estimating cancer potency from animal data. Thus, Ames’ approach to using laboratory animal data to evaluate human cancer risk is in sharp contrast to the criteria and scientific judgments used by the National Toxicology Program (NTP), International Agency for Research on Cancer (IARC), and EPA. We can only surmise that the objective is to discredit the use of animal data for assessing human risk.

In addition, there are several noteworthy inconsistencies in Ames’ use of the HERP index to evaluate human risk. The first involves the use of cancer risk estimates from ‘high-dose’ animal studies. On the one hand, Ames states that using laboratory animal studies to predict cancer risk in humans is a ‘bankrupt’ approach that should be abandoned (27) . On the other hand, the TD50 used as the denominator of the HERP index, an index Ames used repeatedly to compare relative human cancer risk, is based entirely on data from animal cancer studies that he criticizes as being unreliable for evaluating human cancer risks. Thus, it appears paradoxical that Ames criticizes the use of animal data for public health decisions when he relies on animal data to generate the HERP indexes for evaluating human risk.

What exactly is the TD50? The TD50 is defined as the daily dose in mg/kg body wt that, if administered chronically for the life span of the species, halves the percent of tumor-free animals at the end of a normal life span (21) . The TD50 can also be described as the daily dose that will induce tumors in half of the test animals that would have remained tumor-free at zero dose. The TD50 is frequently near the range of the highest dose used in the cancer bioassay or, in many cases, is even higher than the highest dose used in the animal cancer study. In the latter instances, the TD50 is obtained by extrapolating data from ‘high-dose animal cancer tests’ to even higher doses. Thus, the ‘high doses’ used in animal tests are a critical part of their HERP index.

Another inconsistency relates to the method of extrapolating risks to low doses. Ames criticizes linear extrapolation, stating that "the possible hazard may be markedly less than linearly proportional" (18) and that "linear extrapolation (from high doses to low) just isn’t credible" (28) . However, relative rankings of carcinogenic hazards using the HERP index are only relevant in assessing human health risk to the extent that they also reflect the relative rankings of these agents at environmentally relevant doses. And this requires linear extrapolation, which is an inherent assumption whenever cancer potency comparisons are based on the HERP index.

A related flaw in the HERP index is the use of TD50 values, as opposed to TD10 or TD01 values, for comparing human cancer risk. Using the TD50 ignores all information relevant to shapes of dose-response curves that could be obtained from the available data. For example, two chemicals may have the same TD50 value, but experimental data may show that one has a supralinear dose response whereas the other has a sublinear dose response. In this example, the supralinear chemical would be expected to have a greater effect than would the sublinear chemical at lower doses. Interpretations of the relative effects of these two chemicals based on their TD50 values would incorrectly portray them as having identical low-dose cancer potencies.

Problems associated with the HERP index are not limited to the use of the TD50 in the denominator. Human exposure doses (the numerator of the HERP index) may also be difficult or impossible to specify with any meaningful accuracy. HERP index values have been reported for the same chemical that vary by as much as 2000-fold with different estimates of daily human exposure and/or associated risk (15 , 19) . Another concern is that daily human exposures are based on a human body weight of 70 kg (154 pounds), not a realistic estimate for most Americans. For individuals, especially children, who may consume the same amount or more of certain foods than do adults (e.g., fruit juices and peanut butter), the daily exposures would be substantially higher than that used to calculate their HERP index values. In addition, this approach does not address differences in susceptibility among individuals or differences in sensitivity during developmental phases of life, e.g., the developing fetus. Thus, risks in women or children may not be adequately captured in evaluations based on exposure estimates for 70 kg men (29) .

Another problem with the use of the HERP index is that it regards single site, single sex species carcinogens as essentially equivalent to those showing multisite, multispecies effects. For example, to report HERP index values for d-limonene (a single-site, single species tumorigen), based on human exposure to orange juice, black pepper, nutmeg, and mango (24) , for comparisons with the hazards of pesticides (e.g., ethylene dibromide, 1,2-dibromo-3-chloropropane) that are carcinogenic in more than one species is misleading with respect to scientific judgment of human risk. d-Limonene, shown to produce kidney tumors only in male rats and frequently cited as a rodent carcinogen that poses a low likelihood of human cancer risk, has been unduly amplified to discredit in general the value of experimental animal data in predicting possible human risk. To the contrary, IARC places d-limonene in group 3 (30) , which is among those chemicals "not classifiable as to its carcinogenicity to humans" because animal data show a single site, single species effect and there are no or inadequate cancer data in humans. NTP likewise does not list d-limonene in its Reports on Carcinogens (31) . Thus, neither the IARC nor the NTP concluded that the experimental results with d-limonene were indicative of a carcinogenic risk for humans. In addition to d-limonene, numerous chemicals included among the rodent carcinogens in the CPDB, such as allyl isothiocyanate, benzyl acetate, crotonaldehyde, petasitenine, senkirkine, and many others, produced results considered insufficient by IARC and the NTP for assessing human risk (31 32 33) .

While the motivation for the establishment of the HERP index appears reasonable, the human exposure assessments and the animal potency values used to calculate HERP numbers are not reliable for comparing potential cancer hazards to humans, especially in potentially sensitive populations such as children. To use HERP numbers to establish regulatory exposure standards would be scientifically unsound.


   THE VALUE OF ANIMAL CANCER DATA: TESTING CHEMICALS DOES NOT MAKE THEM CARCINOGENS
TOP
ABSTRACT
INTRODUCTION
THE HERP INDEX: IS...
THE VALUE OF ANIMAL...
HEALTH RISKS FROM NATURAL...
ALLEGED MISCONCEPTIONS: HAVE THE...
DISCUSSION
CONCLUSION
REFERENCES
 
The first identified exogenous causes of human cancer were chemicals: tobacco snuff, chimney soot, arsenic, and aromatic amines. The other two main groups of exogenous causes of cancer—ionizing radiation and biological agents—were recognized much later (7) . There is little doubt that chemicals cause cancer, yet fortunately very few appear to do so. (34) .

The role of long-term animal tests for identifying carcinogens is primarily to provide reliable information on the capacity of an agent to produce cancer in mammalian systems and to contribute to decisions that would lead to better protection of human health. There is also good evidence that experimental results correlate well with observations in humans. Animal data on the carcinogenicity of a variety of chemicals have preceded as well as predicted later epidemiological observations in humans (35 36 37) .

The experimental approach to the identification of the causes and estimations of human cancer risks is improving by making greater use of our increased understanding of the toxicokinetics of environmental carcinogens and of new insights on mechanisms of carcinogenesis (38) . Strong evidence exists that experimental results can be extrapolated qualitatively to the human situation. Nonetheless, expanded efforts are continuing to reduce or eliminate uncertainties in quantitative risk assessments.

Using data in the CPDB has led to the opinion that ~50% of all chemicals tested for carcinogenicity in rats and mice are positive in at least one experiment (18 , 23) . Unfortunately, the criteria on which the evidence of carcinogenicity for chemicals in the CPDB is based are not evaluated critically. A chemical is simply classified as a carcinogen "if it has been evaluated as positive by the author of at least one experiment" (20) . This is at variance with criteria adopted by the IARC and by the NTP whereby expert scientific panels carefully and critically assess all available experimental data before drawing conclusions on the strength of evidence of potential carcinogenic risk to humans. A large proportion of chemicals selected for carcinogenicity studies was based on an a priori suspicion of carcinogenic activity (34 , 39) .

The high proportion of ‘carcinogenic’ chemicals in the CPDB is in sharp contrast with the lower proportion of chemicals found to have evidence sufficient to be classified by IARC as human carcinogens or as probable human carcinogens. In contrast to the CPDB, the database of the IARC Monographs indicates that of the 850 chemicals evaluated within the program, 35% were found to have sufficient experimental evidence of carcinogenicity in laboratory animals and are therefore described as carcinogens, 30% exhibited limited evidence of carcinogenicity, and 35% had inadequate evidence of carcinogenicity (40) . Significantly, only 8.6% of these 850 agents are considered by IARC as ‘carcinogenic to humans’ and 6.7% as ‘probably carcinogenic to humans’. Thus, the CPDB overestimates by at least three- to fourfold the number of potential human carcinogens. Ames and Gold (41) recognize that "carcinogens clearly are not all the same" and that some agents are positive in two species while others show carcinogenic effects in only one sex of one strain, but in compiling tables for ranking possible carcinogenic hazards from natural and synthetic chemicals, different levels of evidence of carcinogenicity are treated as if they were equivalent. For instance, evidence of carcinogenicity of d-limonene and of 1,3-butadiene is treated as if they were actually comparable, when in fact they are not; d-limonene is ‘unclassifiable’ whereas 1,3-butadiene is a human carcinogen (31) . Many chemicals listed in the CPDB are not considered as probably or reasonably anticipated carcinogens by either IARC or NTP.


   HEALTH RISKS FROM NATURAL CHEMICALS VS. SYNTHETIC CHEMICALS
TOP
ABSTRACT
INTRODUCTION
THE HERP INDEX: IS...
THE VALUE OF ANIMAL...
HEALTH RISKS FROM NATURAL...
ALLEGED MISCONCEPTIONS: HAVE THE...
DISCUSSION
CONCLUSION
REFERENCES
 
Is there really a misconception that the toxicity of synthetic chemicals is different from that of natural chemicals (42) ? On the contrary, it is common knowledge that chemicals existed before the birth of the chemical industry and that natural chemicals, similar to synthetic chemicals, can be biologically active or even toxic. Synthetic chemicals differ in their toxicity, some are very hazardous to human health and others are relatively inactive. Certainly, the toxicity of synthetic and natural chemicals may be similar in some cases and different in others. A basic objective of toxicity testing is to identify the hazardous chemicals in our environment and characterize their potential to induce adverse effects in exposed human populations. Carcinogenic synthetic pesticides constitute a risk no matter what the prevalence of natural chemicals, which may or may not be true pesticides. There is no interdependence among natural and synthetic pesticides; consequently, the risks of each chemical in whichever category one lists them must be evaluated independently. Obviously, combination and synergistic effects must also be considered.

Natural carcinogens and anticarcinogens present in food are considered by Ames and colleagues to be more important determinants of cancer risk than synthetic carcinogens. Yet no epidemiological data support the notion that prevention of exposure to natural carcinogens in food reduces cancer risk, and results from clinical trials have failed so far to show that specific natural anticarcinogens reduce cancer risk (43 , 44) . In contrast, reductions in exposure to synthetic chemicals in the working environment have been shown to reduce cancer risks in humans (9) .

A major component of the estimated daily consumption of ‘natural pesticides’ is based on the assumed average daily intake of coffee and of chlorogenic acid, neochlorogenic acid, and caffeic acid contained therein (20) . However, large segments of the population do not consume coffee or plants that have a relatively high content of caffeic and chlorogenic acid. Most, if not all, so-called natural pesticides are ingested together with substances that exert a protective or anticarcinogenic effect, e.g., fruits and vegetables that are associated with lower risks of cancer. Further, risk is based on the amounts of carcinogens consumed (dose) as well as the potency of the putative carcinogenic agent(s). Focusing solely on amounts of natural vs. synthetic pesticides consumed per day does not address large differences in consumption or cancer potencies or on coingestion of other carcinogens and of anticarcinogens.

Attempts to distinguish between naturally occurring and synthetic chemicals are fraught with difficulties. For instance, it is probably more appropriate to define as human-made (synthetic), rather than natural, manufactured items containing ‘natural chemicals’ such as nickel, chromium, cadmium, or arsenic, and their compounds or tobacco products, asbestos, and fiberglass, TCDD, gasoline, and many other substances. This is because human exposures to many of these agents would not likely occur if it were not for industrial activities. Tobacco leaves are natural products, but cigarette smoke, as it is inhaled, may be more accurately described as a manufactured product. Asbestos is another classic ‘natural’ agent that would not be the deadly problem it is without human intervention to make it a widely used and distributed product. Dioxins exist in our environment largely as a byproduct of waste incineration, paper bleaching, and herbicide manufacture. Clear distinctions between natural and synthetic chemicals are not always obvious; hence, the notion that consumption of ‘natural plant pesticides’ in our diets pose a greater health risk than do synthetic pesticides residues in our foods is misleading and should be viewed as an unproved hypothesis. Denying any potential harm of carcinogenic pesticide residues on fruits and vegetables or in their products (e.g., juices) does not promote improved public health, especially for susceptible members of our society (29) .


   ALLEGED MISCONCEPTIONS: HAVE THE SCIENTIFIC AND PUBLIC HEALTH COMMUNITIES MISLED THE GENERAL PUBLIC REGARDING ENVIRONMENTAL CANCER RISKS?
TOP
ABSTRACT
INTRODUCTION
THE HERP INDEX: IS...
THE VALUE OF ANIMAL...
HEALTH RISKS FROM NATURAL...
ALLEGED MISCONCEPTIONS: HAVE THE...
DISCUSSION
CONCLUSION
REFERENCES
 
In this section, Ames’ nine misconceptions are listed, along with the facts and our reasoning on each of these issues.

‘Misconception’ 1: Cancer rates are soaring
Fact: Cancer rates are high
Although cancer rates are not necessarily ‘soaring’, incidence and mortality rates remain high, and cancer is the second leading cause of death in the U.S., with more than 2 million new cases per year. Further, approximately one in every three or four humans in the U.S. will develop cancer in their lifetime. Thus, it is only prudent to pursue public health measures that are likely to reduce the risk of preventable cancers related to exposures to environmental chemicals. Because a sizable proportion of cancers is preventable, the occurrence of large numbers of avoidable cancer cases and associated deaths is a circumstance that society should seek to reduce.

‘Misconception’ 2: Environmental synthetic chemicals are an important cause of human cancer
Fact: Collective exposures to certain synthetic and natural chemicals may be important causes of cancer, especially to those individuals who are at greatest risk
Cancer is thought to be a consequence of genetic and environmental factors, and there are no accurate estimates of the percentage of cancers directly attributable to exposure to occupational or environmental carcinogens. However, even a small percent of 2 million new cancer cases per year is a significant number. Moreover, the distinction between natural and synthetic chemicals is not always obvious or prudent. For example, asbestos, tobacco, and petroleum products are natural substances that are processed and widely distributed only because of human intervention. Although people make their own lifestyle decisions (i.e., voluntary risks resulting from smoking, obesity, etc.), we expect our air, water, soil, food, and workplaces to pose little or no risk from cancer-causing pollutants (involuntary risks).

‘Misconception’ 3: Reducing pesticide residues is an effective way to prevent diet-related cancer
Fact: Cancer rates would be higher if carcinogenic pesticides were not regulated
Obviously, a healthy diet should include consumption of fruits and vegetables. However, pesticides are intended to kill living organisms, and pesticide residues in or on our food have no known health benefit. Thus, public health can be better served by eliminating or sharply reducing pesticide residues, especially those demonstrated to have carcinogenic potential in laboratory animals or exposed human populations (e.g., farm workers). Denying any potential harm of carcinogenic pesticide residues in foods is neither scientifically defensible nor a prudent public health position.

‘Misconception’ 4: Human exposures to carcinogens and other potential hazards are primarily to synthetic chemicals
Fact: Humans are exposed to both natural and synthetic mutagens and carcinogens and reduction of exposure to these chemicals will reduce cancer risks. The majority of natural chemicals that humans ingest are not carcinogenic.
The claim that more than 99.99% of ingested pesticides are natural in origin and less than 0.01% are synthetic pesticides residues (20) is both exaggerated and misleading with respect to human cancer risks. For example, these numbers refer to pesticides in general and do not distinguish carcinogenic pesticides (synthetic or natural) from noncarcinogenic pesticides. Second, even if these estimated values were limited to natural and synthetic pesticides that are carcinogenic, the comparison is flawed because it ignores differences in cancer potency, which may be very great among these chemicals. It should be noted that there is no evidence demonstrating that all chemicals produced by plants for protection against environmental insults can be labeled as natural carcinogenic pesticides. Third, as discussed above, the borderline between natural and human-made (synthetic) chemicals is also rather blurred. Fourth, there is no interdependence among natural and synthetic pesticides, consequently the risk of each chemical must be evaluated independently. Carcinogenic pesticides constitute a risk no matter what the prevalence is of natural chemicals.

‘Misconception’ 5: Cancer risks to humans can be assessed by standard high-dose animal cancer tests
Fact: Both laboratory animal bioassays and human epidemiology studies are important for identifying human carcinogens
While epidemiological studies provide the most direct evidence of adverse health effects, design and conduct of these typically retrospective studies and the analyses of human data are very costly and time consuming (9 , 11) , and may often lack adequate sensitivity. In addition, accurate descriptions of past exposure circumstances are often difficult to reconstruct. If cancer risks were to be assessed only from epidemiological evidence of affected individuals, then the implementation of public health decisions to reduce or eliminate exposures would require 30 years or more of prior exposure to provide sufficient numbers of cancer deaths to ascertain human cancer causation. This practice would have grave human consequences and is unacceptable.

In laboratory animal studies, exposure levels can be carefully controlled and potentially confounding factors eliminated. Moreover, in many instances animal cancer data have preceded or could have predicted later epidemiological observations in humans (35 , 36) . All human carcinogens that have been tested adequately have been shown to be carcinogenic in animal studies (45) . Thus, we agree with the IARC (37) and the NTP (31) that in the absence of comprehensive human data, well-conducted animal studies are the most definitive means of assessing human cancer risk. In contrast, Ames disagrees with IARC and NTP, stating that "I don’t think animal cancer tests are very useful for saying anything about human cancer" (46) . However, he does not propose any alternative experimental approach that could be used to assess human cancer risk in a predictive manner.

‘Misconception’ 6: Synthetic chemicals pose greater carcinogenic hazards than natural chemicals
Fact: Natural and synthetic chemicals vary in their carcinogenic potency
Most occupational and environmental exposures to chemical pollutants come from synthetic chemical processes and discharges. Occupationally, synthetic chemicals do pose a greater cancer risk to workers. The notion that consumption of ‘natural plant pesticides’ in our diets poses a greater health risk than synthetic pesticide residues in our foods must be viewed as an unproved hypothesis lacking scientific credibility. See section on natural and synthetic chemicals above and response to misconception 4 for more on this issue.

‘Misconception’ 7: The toxicity of synthetic chemicals is different from that of natural chemicals
Fact: The toxicity of synthetic and natural chemicals will be different in some cases and similar in others
Although the toxicities of individual chemicals may vary, there are no basic differences in the basic toxicology of natural and synthetic chemicals. Characterizing the behavior of a chemical and its reactivity in biological systems is more important than specifying its source as natural or synthetic.

‘Misconception’ 8: Pesticides and other synthetic chemicals are disrupting human hormones
Fact: Hormone disrupting chemicals do affect wildlife and humans, and the potential risks of environmental endocrine disruptors to humans need to be more fully determined
The plausibility that environmental endocrine disruptors may affect humans is based to a large extent on the known carcinogenic effects of diethylstilbestrol (DES, a synthetic estrogen) (47) and other estrogens, as well as observations of effects in wildlife species exposed to various organochlorine compounds and endocrine disrupters. Health effects at environmental exposure levels, especially during critical stages of development, have not been fully characterized. This is an important and active area of research that cannot be dismissed by simple denial.

‘Misconception’ 9: Regulating low hypothetical risks advances public health
Fact: Science-based approaches to risk assessment are necessary for sound public health decisions
When a chemical shows carcinogenic effects in laboratory animals, then a prudent public health policy is to limit human exposures. History has certainly validated this public health strategy. Risks may be ‘low’ and ‘hypothetical’ only to those who are unaffected or do not share equally in the benefits of reduced exposure. Concomitant exposures to low levels of many carcinogens and mutagens must be viewed with caution, especially since risk evaluations are typically based on single compounds.


   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
THE HERP INDEX: IS...
THE VALUE OF ANIMAL...
HEALTH RISKS FROM NATURAL...
ALLEGED MISCONCEPTIONS: HAVE THE...
DISCUSSION
CONCLUSION
REFERENCES
 
In a series of papers published since 1984 (19 , 20 , 22 , 24 , 25 , 41 , 48 , 49) , Ames and colleagues have formulated an expanding list of alleged myths or misconceptions that discount 1) the relationship between exposure to environmental hazards and risk of human cancer, 2) the relative importance of synthetic vs. natural chemicals, 3) the relevance of using laboratory animals to identify chemical carcinogens, and 4) priorities for cancer prevention and control. However, as noted above, these declared misconceptions are based on several flawed assumptions. For example, scientists are not claiming that cancer rates are soaring, and there are no basic differences in the toxicology between natural and synthetic chemicals.

More recently, Ames and Gold (50) have again opined that regulations aimed at reducing exposure to synthetic carcinogenic chemicals are actually damaging to public health because they divert resources and distract the public from the major causes of cancer. We contend that scientific-based approaches for assessing health risks of synthetic chemicals are necessary for sound public health decisions, especially for the most vulnerable subgroups in our society. Disease prevention strategies cannot rely on agenda-driven proclamations made by some individuals regarding what constitutes miniscule hypothetical risks.

Cancer is a collection of multifactorial typically lethal diseases involving a complex interplay among multiple genetic, environmental, and host factors. The likelihood of an individual developing cancer in response to a carcinogenic agent or agents is a consequence of several interacting factors including the actual exposure circumstances, genetic factors, diet, lifestyle, health, age, and gender. In addition, the level of exposure that may be assessed as having a low probability of risk when considering a single agent may elicit a greater risk when taking into account multiple and varied exposures to other carcinogens or modifying agents (4 , 7 , 51) .

To disregard experimental results as predictive of potential human hazard may have serious consequences, as past experience has shown. A dramatic example is that of DES: this synthetic estrogen was given for years to pregnant women to prevent miscarriages, while ignoring the experimental evidence of its carcinogenicity; the unfortunate outcome of this mistake was the high rate of vaginal cancers detected in DES daughters (32 , 47) .

The nine alleged misconceptions formulated to support the contention that exposure to industrial and synthetic chemicals represents only a negligible cancer risk to humans relies heavily on their HERP ranking system (19) . This system is purported to put into perspective the hazards of selected synthetic chemicals against the background of natural rodent carcinogens. Our evaluation of the HERP index revealed several inconsistencies and serious flaws in the suppositions underlying this ranking procedure, rendering it unreliable for comparing potential hazards in the general population. Further, the HERP ranking procedure does not attempt to address differences in susceptibility among subpopulations (e.g., children, immune compromised, and genetically susceptible individuals) or the uneven distribution of exposure in the general population.

A conspicuous proportion of human cancers, varying between 35% and 40%, has been attributed to diet (3 , 4 , 48) . However, the evidence of causal associations between specific dietary components and human cancer are mostly circumstantial, and certainly much weaker than the causal associations between numerous occupational and environmental agents and human cancer (9 , 45) . Humans are exposed through diet to a great variety of chemicals, both natural and synthetic, some of which represent a hazard to human health, whereas others have a protective effect. Pesticides may have an indirect protective effect by improving the quantity of certain foods, but there are no data showing that pesticide residues in food provide any health benefit. Instead, there is evidence that some of them are indeed hazardous to health.

One considerable difference to note is that exposure to naturally occurring hazardous chemicals present in our food is generally combined with exposures to chemicals having a protective effect. Exposure to industrial chemicals generally occurs without such mitigating effects. For instance, vitamins and dietary polyphenols may inhibit the formation of N-nitroso compounds from ingested or endogenously formed precursors, but would have little effect on exposure to preformed N-nitroso compounds in the working environment (52) .

When addressing their ‘major’ risk factors of human cancer (48) , Ames and colleagues appear to have ignored the role of low-dose human exposures to agents that, in many instances, were identified as carcinogens in the workplace and are therefore generally labeled as being occupational carcinogens. Occupational carcinogens, however, such as asbestos, vinyl chloride, benzene, 1,3-butadiene, and many others do not cease to be carcinogenic when exposures are encountered outside the workplace environment.

Difficulties in accurately assessing cancer risks due to low-level exposure to multiple carcinogens do not warrant the denial of these risks. Levels of ‘acceptable’ risk from exposure to carcinogens are policy decisions based on public health protection and on a variety of other considerations, including political, social, technological, and economic factors. Regulatory decisions for protection against cancer-causing agents are initially based on predicted increases in risks of 1 per 1000 for occupational exposures and 1 per million for environmental exposures. In contrast, Ames suggests that regulatory efforts should be limited to "worrying about the 1-in-10, 1-in-100, or 1-in-1000 risks" (53) . This suggestion translates to 270 thousand to 27 million additional cancer cases in the United States, an unacceptable level by any standard. The implication that lesser risks are unimportant is an unacceptable public health position. Simply claiming that the "very low levels of chemicals to which humans are exposed through water pollution or synthetic pesticides residues are likely to pose no or minimal risks" (48) or that "the EPA kills people" (54) (by restricting permissible pesticide residues in foods, which Ames claims makes fruits and vegetables economically unaffordable) is counterproductive rhetoric for the development of sound public health policies.

A reasonable and justified public health approach should emphasize the search for safe chemicals that do not represent any hazard to human health or the environment and attempt to eliminate or sharply reduce exposures to those chemicals that have been identified as hazardous. To screen or test chemicals for their possible mutagenic and carcinogenic activity before or after their introduction into the general environment represents a plain, efficient, and reliably predictive disease prevention strategy. In a similar manner, the systematic screening of chemicals due to become medical drugs, if carefully implemented, decreases the likelihood that new drugs with dangerous side effects will be marketed. The requirement that pesticides be evaluated for their possible adverse effects on human health is not equivalent to declaring that all pesticides are necessarily harmful to humans. It is simply a rational decision guided by the intention of avoiding past mistakes and the view that protection of public health is a goal that society should always pursue.


   CONCLUSION
TOP
ABSTRACT
INTRODUCTION
THE HERP INDEX: IS...
THE VALUE OF ANIMAL...
HEALTH RISKS FROM NATURAL...
ALLEGED MISCONCEPTIONS: HAVE THE...
DISCUSSION
CONCLUSION
REFERENCES
 
Awareness of the plurality of exposures and of their possible interactions, which may occur simultaneously or at different times in individuals with different susceptibilities, should orient society as well as the scientific community toward prudent evaluations of risk and cautious primary prevention. With respect to carcinogenic risks, Ames and colleagues advocate that exposures to industrial and synthetic chemicals represent little risk to humans. To support this opinion, they have formulated nine alleged misconceptions in chemical carcinogenesis that have presumably misled the public with respect to 1) health risks from pesticide residues and other environmental pollutants, 2) methods of identifying chemical carcinogens, and 3) cancer prevention strategies. While rejecting the value of animal studies, Ames proposes no new methods to identify carcinogens.

Our evaluation of these alleged misconceptions reveals that they are based on flawed and untested assumptions, as well as on faulty scientific judgment. Hence, we believe that in the absence of human data, laboratory animal studies are the most definitive means for assessing carcinogenic potential, and that any reliance on these misconceptions in policy decisions for cancer prevention could have deleterious consequences to human health. To dismiss the role of synthetic or human-made chemicals in the causation of human cancers and to oppose science-based regulatory efforts aimed at reducing exposure to hazardous synthetic and industrial chemicals is a perspective that ignores the value of the precautionary approach for protection of public health. To reject animal carcinogenicity studies for evaluating potential human cancer risks would unfortunately lead to human cancer cases as the only means of demonstrating carcinogenicity of environmental agents. This is unacceptable. We believe that the identification of hazardous chemicals by sound scientific methods and reduction in human and wildlife exposures to such agents will lead to a healthier environment for present and future generations.


   ACKNOWLEDGMENTS
 
We thank Dr. John Bucher for his helpful comments and suggestions.


   FOOTNOTES
 
1 Present address: Cave 25/r, 34011 Aurisina, Trieste, Italy.

2 Present address: National Cancer Institute, Bethesda, MD 20892, USA.

Received for publication December 16, 1999. Revision received July 14, 2000.
   REFERENCES
TOP
ABSTRACT
INTRODUCTION
THE HERP INDEX: IS...
THE VALUE OF ANIMAL...
HEALTH RISKS FROM NATURAL...
ALLEGED MISCONCEPTIONS: HAVE THE...
DISCUSSION
CONCLUSION
REFERENCES
 

  1. Greenlee, R. T., Murray, T., Bolden, S., Wingo, P. A. (2000) Cancer statistics, 2000. CA Cancer J. Clin. 50,7-33[Abstract]
  2. ACS Cancer Facts & Figures—2000. American Cancer Society, Atlanta, Georgia
  3. Doll, R., Peto, R. (1981) The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst. 66,1191-1308
  4. Schmahl, D., Preussman, R., Berger, M. R. (1989) Causes of cancer—an alternative view to Doll and Peto. Klin. Wochenschr. 67,1169-1173[Medline]
  5. Wynder, E. I., Gori, G. B. (1977) Contribution of the environment to cancer incidence: an epidemiological exercise. J. Natl. Cancer Inst. 58,825-832
  6. Higginson, J., Muir, C. S. (1979) Environmental carcinogenesis: misconceptions and limitations to cancer control. J. Natl. Cancer Inst. 63,365-384
  7. Tomatis, L., Aitio, A., Heseltine, E., Kaldor, J., Miller, A. B., Parkin, D. M., and Riboli, E. (1990) Cancer: causes, occurrence and control, IARC Sci. Pub. 100, 352 pp., Lyon, France
  8. Doll, R. (1967) Prevention of cancer: pointers from epidemiology The Nuffield Provincial Hospital Trust and Rock Carling Fellowship London.
  9. Tomatis, L., Huff, J., Hertz-Picciotto, I., Dandler, D. P., Bucher, J., Boffetta, P., Axelson, O., Blair, A., Taylor, J., Stayner, L., Barrett, J. C. (1997) Avoided and avoidable risks of cancer. Carcinogenesis 18,97-105[Abstract/Free Full Text]
  10. Bailar, J. C., Gornik, H. L. (1997) Cancer undefeated. New. Engl. J. Med. 336,1569-1574[Abstract/Free Full Text]
  11. Huff, J. (1999) Value, validity, and historical development of carcinogenesis studies for predicting and confirming carcinogenic risks to humans. Kitchin, K. T. eds. Carcinogenicity: Testing, Predicting, and Interpreting Chemical Effects ,21-123 Marcel Dekker New York.
  12. . Environmental Protection Agency (EPA) (1997) Chem. Prog 18,1-3
  13. Jasny, B. R., Bloom, F. E. (1998) It’s not rocket science—but it can save lives. Science 280,1507
  14. Wingo, P. A., Ries, L. A., Giovino, G. A., Miller, D. S., Rosenberg, H. M., Shopland, D. R., Thun, M. J., Edwards, B. K. (1999) Annual report to the nation on the status of cancer 1973–1996, with a special section on lung cancer and tobacco smoking. J. Natl. Cancer Inst. 91,675-690[Abstract/Free Full Text]
  15. Ames, B. N., McCann, J. (1976) Carcinogens are mutagens: A simple test system. Montesano, R. Bartsch, H. Tomatis, L. eds. Screening Tests in Chemical Carcinogenesis ,493-498 Scientific Publication No. 12, International Agency for Research on Cancer Lyon, France.
  16. Blum, A., Ames, B. N. (1977) Flame-retardant additives as possible cancer hazards. Science 195,17-23[Free Full Text]
  17. McCann, J., Ames, B. N. (1977) The Salmonella/microsome mutagenicity test: predictive value for animal carcinogenicity. Hiatt, H. H. Watson, J. D. Winsten, J. A. eds. Origins of Human Cancer ,1431-1450 Cold Spring Harbor Laboratory Press Cold Spring Harbor, N.Y..
  18. Ames, B. N., Magaw, R., Gold, L. S. (1987) Ranking possible carcinogenic hazards. Science 236,271-280[Abstract/Free Full Text]
  19. Ames, B. N., Gold, L. S. (1997) Pollution, pesticides and cancer misconceptions. FASEB J 11,1041-1052[Abstract]
  20. Ames, B. N., Profet, M., Gold, L. S. (1990) Dietary pesticides (99.99% all natural). Proc. Natl. Acad. Sci. USA 87,7777-7781[Abstract/Free Full Text]
  21. Peto, R., Pike, M. C., Bernstein, L., Gold, L. S., Ames, B. N. (1984) The TD50: A proposed general convention for the numerical description of the carcinogenic potency of chemicals in chronic-exposure animal experiments. Environ. Health. Perspect. 58,1-8[Medline]
  22. Gold, L. S., Sawyer, C. B., Magaw, R., Backman, G. M., deVeciana, M., Levinson, R., Hooper, N. K., Havender, W. R., Bernstein, L., Peto, R., Pike, M. C., Ames, B. N. (1984) Carcinogenic potency database of the standardized results of animal bioassays. Environ. Health. Perspect. 58,9-319[Medline]
  23. Gold, L. S. Zeiger, E. eds. Handbook of Carcinogenic Potency and Genotoxicity Databases 1997 CRC Press Boca Raton, Fla.
  24. Gold, L. S., Slone, T. H., Stern, B. R., Manley, N. B., Ames, B. N. (1992) Rodent carcinogens: setting priorities. Science 258,261-265[Abstract/Free Full Text]
  25. Ames, B. N., Gold, L. S. (1990) Dietary carcinogens, environmental pollution, and cancer: Some misconceptions. Med. Oncol. Tumor Pharmacother. 7,69-85[Medline]
  26. HTTP://WWW.Reason.com/amesint.html. (1991)
  27. Business Week (1990) October 15, p. 58
  28. Food Chemical News (1991) August 5, p. 6
  29. . National Research Council (1993) Pesticides in the Diets of Infants and Children National Academy of Sciences Washington, D.C..
  30. . IARC (1993) d-Limonene. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 56 International Agency for Research on Cancer Lyon, France.
  31. Ninth Report on Carcinogens 2000,27709-22510 National Toxicology Program Research Triangle Park, NC.
  32. . IARC (1987) Monographs on the Evaluation of Carcinogenic Risk to Humans Lyon, France. Suppl. 7
  33. . IARC (1995) Monographs on the Evaluation of Carcinogenic Risk to Humans 63 International Agency for Research on Cancer Lyon, France.
  34. Fung, V. A., Barrrett, J. C., Huff, J. E. (1995) The carcinogenesis bioassay in perspective: application in identifying human cancer hazards. Environ. Health. Perspect. 103,680-683[Medline]
  35. Tomatis, L. (1979) The predictive value of rodent carcinogenicity tests in the evaluation of human risks. Annu. Rev. Pharmacol. Toxicol. 19,511-530[Medline]
  36. Huff, J. E. (1993) Chemicals and cancer in humans: first evidence in experimental animals. Environ. Health Perspect. 100,201-210[Medline]
  37. . IARC Preamble (2000) Some Industrial Chemicals. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 77 International Agency for Research on Cancer Lyon, France.
  38. Vainio, H., Magee, P., McGregor, D., McMichael, A. J. (1992) Mechanisms of Carcinogenesis in Risk Identification. IARC Sci. Publ. No. 116 International Agency for Research on Cancer Lyon, France.
  39. Fung, V. A., Huff, J., Weisburger, E., Hoel, D. G. (1993) Predictive strategies for selecting 379 NCI/NTP chemicals evaluated for carcinogenic potential: scientific and public health impact. Fund. Appl. Toxicol. 20,413-436[Medline]
  40. Tomatis, L., and Wilbourn, J. (1993) Evaluation of carcinogenic risk to humans: The experience of IARC. In New Frontiers in Cancer Causation (Iversen O. H., ed) pp. 371–387, Taylor & Francis, Washington, D.C.
  41. Ames, B. N., Gold, L. S. (1990) Chemical carcinogenesis: Too many rodent carcinogens. Proc. Natl. Acad. Sci. USA 87,7772-7776[Abstract/Free Full Text]
  42. Ames, B. N., Gold, L. S. (1997) The causes and prevention of cancer: gaining perspective. Environ. Health. Perspect. 105,865-873
  43. Omenn, G. S., Goodman, G. E., Thorquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., Barnhart, S., Hammar, S. (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N. Engl. J. Med. 334,1150-1155[Abstract/Free Full Text]
  44. . Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330,1029-1035[Abstract/Free Full Text]
  45. Huff, J. E. (1994) Chemicals associated with cancer in humans and in laboratory animals. Waalkes, M. P. Ward, J. M. eds. Carcinogenesis ,35-37 Raven Press New York.
  46. Washington Post, August 31, 1990, p. A3
  47. Herbst, A. L., Bern, H. A. (1981) Developmental Effects of Diethylstilbestrol (DES) in Pregnancy Thieme-Stratton New York, N.Y..
  48. Ames, B. N., Gold, L. S., Willett, W. C. (1995) The causes and prevention of cancer. Proc. Natl. Acad. Sci. USA 92,5258-5265[Abstract/Free Full Text]
  49. Gold, L. S., Slone, T. H., Ames, B. N. (1998) What do animal cancer tests tell us about human cancer risk? Overview of analyses of the carcinogenic potency database. Drug Metab. Rev. 30,359-404[Medline]
  50. Ames, B. N., Gold, L. S. (2000) Paracelsus to parascience: the environmental cancer distraction. Mutat. Res. 447,3-13[Medline]
  51. Sugimura, T. (1992) Multistep carcinogenesis: a 1992 perspective. Science 258,603-607[Abstract/Free Full Text]
  52. Bartsch, H., and Spiegelhader, B. (1996) Environmental exposure to N-nitroso compounds (NNOC) and precursors: an overview. Eur. J. Cancer Prev. 5 (Suppl. 1), 11–17
  53. Food Chemical News, August 26, 1991, p. 23
  54. Forbes, October 25, 1993, pp. 104–108



This article has been cited by other articles:


Home page
BioinformaticsHome page
J. W. Arthur, A. Sanchez-Perez, and D. I. Cook
Scoring of predicted GRK2 phosphorylation sites in Nedd4-2
Bioinformatics, September 15, 2006; 22(18): 2192 - 2195.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Public HealthHome page
R. L. Melnick
A Daubert Motion: A Legal Strategy to Exclude Essential Scientific Evidence in Toxic Tort Litigation
Am J Public Health, July 1, 2005; 95(S1): S30 - S34.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
R.R. Maronpot, G. Flake, and A. J. Huff
Relevance of Animal Carcinogenesis Findings to Human Cancer Predictions and Prevention
Toxicol Pathol, January 1, 2004; 32(1_suppl): 40 - 48.
[Abstract] [PDF]


Home page
Toxicol SciHome page
J. Huff
Carcinogenicity of Bisphenol A Revisited
Toxicol. Sci., December 1, 2002; 70(2): 281 - 283.
[Full Text] [PDF]


Home page
Toxicol PatholHome page
G. A. Boorman, J. K. Haseman, M. D. Waters, J. F. Hardisty, and R. C. Sills
Quality Review Procedures Necessary for Rodent Pathology Databases and Toxicogenomic Studies: The National Toxicology Program Experience
Toxicol Pathol, January 1, 2002; 30(1): 88 - 92.
[Abstract] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TOMATIS, L.
Right arrow Articles by HUFF, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TOMATIS, L.
Right arrow Articles by HUFF, J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS